GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shire PLC (NAS:SHPG) » Definitions » Price-to-Tangible-Book

Shire (SHPG) Price-to-Tangible-Book : (As of Apr. 26, 2024)


View and export this data going back to 1998. Start your Free Trial

What is Shire Price-to-Tangible-Book?

As of today (2024-04-26), Shire's share price is $179.20. Shire's Tangible Book per Share of Sep. 2018 for the quarter that ended in Sep. 2018 was $-37.49. Hence, Shire's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Shire's Price-to-Tangible-Book or its related term are showing as below:

SHPG's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 2.68
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Shire's share price is $179.20. Shire's Book Value per Sharefor the quarter that ended in Sep. 2018 was $122.30. Hence, Shire's P/B Ratio of today is 1.47.


Shire Price-to-Tangible-Book Historical Data

The historical data trend for Shire's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shire Price-to-Tangible-Book Chart

Shire Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.33 33.26 - - -

Shire Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Shire's Price-to-Tangible-Book

For the Biotechnology subindustry, Shire's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shire's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shire's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Shire's Price-to-Tangible-Book falls into.



Shire Price-to-Tangible-Book Calculation

Shire's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Sep. 2018 )
=179.20/-37.488
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Shire Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Shire's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Shire (SHPG) Business Description

Traded in Other Exchanges
N/A
Address
Shire is a diversified, Ireland-based specialty drug firm. Shire has grown primarily through mergers and acquisitions, including the Transkaryotic Therapies acquisition in 2005, which established its genetic disease business with Replagal and Elaprase, and the merger with New River in 2007, which brought full rights to neuroscience drug Vyvanse. Shire completed the acquisition of ViroPharma (genetic diseases) in 2014, NPS Pharma (internal medicine) in 2015, and Baxalta (hematology, immunology, and oncology) and Dyax (genetic diseases) in 2016.
Executives
James H Cavanaugh director 265 HOTHORPE LANE, VILLANOVA PA 19085

Shire (SHPG) Headlines

From GuruFocus

David Abrams Buys 3 Stocks in 3rd Quarter

By Sydnee Gatewood Sydnee Gatewood 11-14-2018

David Abrams Buys Shire, Boosts Lithia Motors

By Tiziano Frateschi Tiziano Frateschi 11-14-2018